Novus Therapeutics Receives FDA Guidance on OP0201 Phase 2a Study in Patients with Chronic Otitis Media with Effusion - BioSpace Get link Facebook X Pinterest Email Other Apps - October 29, 2019 Novus Therapeutics Receives FDA Guidance on OP0201 Phase 2a Study in Patients with Chronic Otitis Media with Effusion BioSpace Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment